References
- Kraszewska MD, Dawidowska M, SzczepanńLski T, . T-cell acute lymphoblastic leukaemia: recent molecular biology findings. Br J Haematol 2012;156:303–315.
- van der Velden VH, Cazzaniga G, Schrauder A, . Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. Leukemia 2007;21:604–611.
- Dawidowska M, Jolkowska J, Szczepanski T, . Implementation of the standard strategy for identification of Ig/TCR targets for minimal residual disease diagnostics in B-cell precursor ALL pediatric patients: Polish experience. Arch Immunol Ther Exp (Warsz) 2008;56:409–418.
- Schrappe M, Valsecchi MG, Bartram CR, . Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. Blood 2011;118:2077–2084.
- Willemse MJ, Seriu T, Hettinger K, . Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL. Blood 2002;99:4386–4393.
- Kraszewska MD, Dawidowska M, Larmonie NS, DNA methylation pattern is altered in childhood T-cell acute lymphoblastic leukemia patients as compared with normal thymic subsets: insights into CpG island methylator phenotype in T-ALL. Leukemia 2011 Aug 12. [Epub ahead of print]
- Szczepanski T, Langerak AW, Willemse MJ, . T cell receptor gamma (TCRG) gene rearrangements in T cell acute lymphoblastic leukemia reflect “end-stage” recombinations: implications for minimal residual disease monitoring. Leukemia 2000;14:1208–1214.
- Szczepanski T, Pongers-Willemse MJ, Langerak AW, . Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6 - 19 and DH7 - 27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor alpha beta lineage. Blood 1999;93:4079–4085.
- Flohr T, Schrauder A, Cazzaniga G, . Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia 2008;22:771–782.
- Asnafi V, Beldjord K, Boulanger E, . Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment. Blood 2003;101:2693–2703.
- Pongers-Willemse MJ, Seriu T, Stolz F, . Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia. Leukemia 1999;13:110–118.
- van Dongen JJ, Langerak AW, Bruggemann M, . Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98 - 3936. Leukemia 2003;17:2257–2317.
- Szczepanski T, van der Velden VH, Raff T, . Comparative analysis of T-cell receptor gene rearrangements at diagnosis and relapse of T-cell acute lymphoblastic leukemia (T-ALL) shows high stability of clonal markers for monitoring of minimal residual disease and reveals the occurrence of second T-ALL. Leukemia 2003;17: 2149–2156.
- Meleshko AN, Lipay NV, Stasevich IV, . Rearrangements of IgH, TCRD and TCRG genes as clonality marker of childhood acute lymphoblastic leukemia. Exp Oncol 2005;27:319–324.
- Asnafi V, Beldjord K, Libura M, . Age-related phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophy. Blood 2004;104:4173–4180.